Source: IOL Author: Kelly Jane Turner 

Cape Town – South African Health Products Regulatory Authority (Sahpra) has announced it will allow a controlled compassionate use of Ivermectin to treat Covid-19.

The health product regulator says it will unveil the access protocols for the drug in the coming days.

The announcement was made during a press announcement in collaboration with the National Press Club on Wednesday.

“We at Sahpra have considered all of this, and the approach that we will be taking going forward is that we will facilitate a controlled, compassionate, access programme for Ivermectin.

“This does not mean that our position changes around the lack of availability of scientific data, but we had to as a regulator have very in-depth discussions around the context which we find ourselves in with the pandemic with limited options,” said Sahpra chief executive Dr Boitumelo Semete-Makokotlela.

“We hope the controlled access will enable us that the product is used properly and limit the black market,” she said

“It’s important to note that Sahpra has listened and heard what people have been saying about Ivermectin.The programme will be open to all patients. We will review every application as it comes through,” said Semete-Makokotlela.

She said healthcare professionals would be central to the application for use in their patients but will unveil the process in more detail in the coming days.

During a hearing before the US senate homeland security and governmental affairs committee last week, Dr Pierre Kory, a pulmonary and critical care specialist at Aurora St Luke’s Medical Center in Milwaukee, described Ivermectin as a “wonder drug” with immensely powerful antiviral and anti-inflammatory agents.

Kory said: “Ivermectin is highly safe, widely available, and low cost. Its discovery was awarded the Nobel Prize in medicine, and is already included on the WHO’s World’s List of Essential Medicines. Ivermectin is effectively a miracle drug against Covid-19.”









Related:
What is Ivermectin? Study shows ‘head lice meds’ cut COVID-19 deaths by 83%

Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

The FLCCC Alliance— On a mission to Save Thousands & Slow the Pandemic

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Top US medics recommend ‘sequenced multidrug therapy’ including HCQ & Ivermectin, for early high-risk COVID-19 infections

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »